FDA Grants Breakthrough Device Designation for Whole Genome and Exome Tests
The designation accelerates regulatory review for GeneDx's ExomeDx and GenomeDx testing platforms designed to diagnose rare diseases.
The designation accelerates regulatory review for GeneDx's ExomeDx and GenomeDx testing platforms designed to diagnose rare diseases.